VolitionRx Ltd
VNRX
24 hedge funds and large institutions have $5.89M invested in VolitionRx Ltd in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
26% more capital invested
Capital invested by funds: $4.66M → $5.89M (+$1.23M)
0.06% more ownership
Funds ownership: 0.41% → 0.47% (+0.06%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
14% less funds holding
Funds holding: 28 → 24 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$1.32M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$58.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$135K |
| 2 |
VF
Virtu Financial
New York
|
-$19K |
| 3 |
Bank of New York Mellon
New York
|
-$15K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.2K |
| 5 |
Jane Street
New York
|
-$10.6K |
VNRX Hedge Fund Activity: Q1 2024 in Review
24 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2024, worth a combined $5.89M — up 26% from $4.66M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VNRX and 2 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Lagoda Investment Management, adding an estimated $1.32M. The largest seller was Morgan Stanley, cutting an estimated $135K.
- 24 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2024, down from 28 in Q4 2023.
- Funds reported $5.89M of VolitionRx Ltd stock for Q1 2024, up 26% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q1 2024 and 6 closed out, a net change of -4 holders.
- The largest VolitionRx Ltd buyer in Q1 2024 was Lagoda Investment Management, an estimated $1.32M added.
- The largest VolitionRx Ltd seller in Q1 2024 was Morgan Stanley, an estimated $135K sold.
Based on aggregated 13F filings for Q1 2024.